A new approach for staging T1D in its earliest presymptomatic stages was released by the JDRF, the Endocrine Society, and the American Diabetes Association. The organizations endorse the concept that autoimmune disease precedes the onset of symptoms and progresses through distinct stages.
A minority of adults and caregivers of children with type 1 diabetes routinely download and review data from diabetes devices, according to data from a cross-sectional survey published in Diabetes Technology and Therapeutics.
Mealtime insulin dosing calculation should focus on meal composition—including fat, protein, and glycemic index—rather than carbohydrate counting alone, according to a systematic review published in the June issue of Diabetes Care.
Management of type 1 diabetes is particularly challenging during adolescence, a time when teens are dealing with physical changes occurring with puberty, social pressures, and stress, among other issues. In addition, researchers from Columbia University have found that mental health issues including depression, anxiety, and disordered eating are common in teenagers and young adults with type 1 diabetes, and are linked to poorly controlled diabetes.
A clinical trial is examining whether an artificial pancreas improves nighttime blood glucose levels in patients with type 1 diabetes. The study is being conducted by the Icahn School of Medicine at Mount Sinai, New York, NY, and is funded by a grant from JDRF.
The findings of this important paper emphasize one specific word: early. It is important to treat these patients with type 1 aggressively and early, when they are either adolescent or young adults, or as soon as they are diagnosed if they are diagnosed in their 20s.
Researchers have developed a multistep protocol that converts human embryonic stem cells into insulin-producing cells that can reverse diabetes in approximately 40 days in an animal model—much faster than the 4 months required for cells produced with previous methods. The goal is to be able transplant these insulin-producing cells for the treatment of type 1 diabetes, researchers reported in a study published in the November issue of Nature Biotechnology.
High albumin levels, but within the normal range, can be used to identify young people with type 1 diabetes at risk of heart and kidney disease, according to a study published online ahead of print in Diabetes Care.
The extent to which patients are compliant with their type 1 diabetes treatment may have an effect on their mortality risk, according to the results of a recent study in the Journal of Diabetes and its Complications.
This information is not designed to replace a physician's independent judgment about the appropriateness or
risks of a procedure for a given patient. Always consult your doctor about your medical conditions. Vertical
Health & EndocrineWeb do not provide medical advice, diagnosis or treatment. Use of this website is
conditional upon your acceptance of our user agreement.